-
1
-
-
0028059590
-
Why have new effective therapies for sepsis not been developed?
-
1. Eidelman L, Sprung CL: Why have new effective therapies for sepsis not been developed? Crit Care Med 1994; 22:1330-1334
-
(1994)
Crit Care Med
, vol.22
, pp. 1330-1334
-
-
Eidelman, L.1
Sprung, C.L.2
-
2
-
-
0029192212
-
Tumor necrosis factor in sepsis: Mediator of multiple organ failure or essential part of host defense
-
2. Van der Poll T, Lowry SI: Tumor necrosis factor in sepsis: mediator of multiple organ failure or essential part of host defense. Shock 1995; 3:1-12
-
(1995)
Shock
, vol.3
, pp. 1-12
-
-
Van Der Poll, T.1
Lowry, S.I.2
-
3
-
-
0027270559
-
Inadequate interleukin-2 synthesis and interleukin-2 messenger expression following thermal and mechanical trauma in humans is caused by defective transmembrane signalling
-
3. Faist E, Schinkel C, Zimmer S, et al: Inadequate interleukin-2 synthesis and interleukin-2 messenger expression following thermal and mechanical trauma in humans is caused by defective transmembrane signalling. J Trauma 1993; 34:846-853; discussion 853-854
-
(1993)
J Trauma
, vol.34
, pp. 846-853
-
-
Faist, E.1
Schinkel, C.2
Zimmer, S.3
-
4
-
-
0030920250
-
Postburn constitutional changes in T-cell reactivity occur in CD8+ rather than in CD4+ cells
-
4. Zedler S, Faist E, Ostermeier B, et al: Postburn constitutional changes in T-cell reactivity occur in CD8+ rather than in CD4+ cells. J Trauma 1997; 42:872-880; discussion 880-881
-
(1997)
J Trauma
, vol.42
, pp. 872-880
-
-
Zedler, S.1
Faist, E.2
Ostermeier, B.3
-
5
-
-
0032917582
-
T-cell reactivity and its predictive role in immunosuppression after burns
-
5. Zedler S, Bone RC, Baue AE, et al: T-cell reactivity and its predictive role in immunosuppression after burns. Crit Care Med 1999; 27:66-72
-
(1999)
Crit Care Med
, vol.27
, pp. 66-72
-
-
Zedler, S.1
Bone, R.C.2
Baue, A.E.3
-
6
-
-
0027469563
-
Detection of intracellular cytokines by flow cytometry
-
6. Jung T, Schauer U, Heusser C, et al: Detection of intracellular cytokines by flow cytometry. J Immunol Methods 1993; 159:197-207
-
(1993)
J Immunol Methods
, vol.159
, pp. 197-207
-
-
Jung, T.1
Schauer, U.2
Heusser, C.3
-
7
-
-
0030587937
-
Immunologic dissonance: A continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS)
-
7. Bone RC: Immunologic dissonance: A continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann Intern Med 1996; 125:680-687
-
(1996)
Ann Intern Med
, vol.125
, pp. 680-687
-
-
Bone, R.C.1
-
8
-
-
0029355466
-
Neutrophil response to endotoxin in the adult respiratory distress syndrome
-
8. Parsons PE, Gillespie MMK, Moore EE, et al: Neutrophil response to endotoxin in the adult respiratory distress syndrome. Am J Respir Cell Mol Biol 1995; 13:152-160
-
(1995)
Am J Respir Cell Mol Biol
, vol.13
, pp. 152-160
-
-
Parsons, P.E.1
Gillespie, M.M.K.2
Moore, E.E.3
-
9
-
-
0029787027
-
Nuclear factor-κβ is activated in alveolar macrophages from patients with acute respiratory distress syndrome
-
9. Schwartz MD, Moore EE, Moore FA, et al: Nuclear factor-κβ is activated in alveolar macrophages from patients with acute respiratory distress syndrome. Crit Care Med 1996; 24: 1285-1292
-
(1996)
Crit Care Med
, vol.24
, pp. 1285-1292
-
-
Schwartz, M.D.1
Moore, E.E.2
Moore, F.A.3
-
10
-
-
0029922017
-
A genetic polymorphism within tumor necrosis factor locus influences plasma tumor necrosis factor-α concentrations and outcome of patients with severe sepsis
-
10. Stüber F, Petersen M, Bokelmann F, et al: A genetic polymorphism within tumor necrosis factor locus influences plasma tumor necrosis factor-α concentrations and outcome of patients with severe sepsis. Crit Care Med 1996; 24:381-384
-
(1996)
Crit Care Med
, vol.24
, pp. 381-384
-
-
Stüber, F.1
Petersen, M.2
Bokelmann, F.3
-
11
-
-
0030746482
-
Antiinflammatory therapies to treat sepsis and septic shock
-
11. Zeni F, Freeman B, Natanson C: Antiinflammatory therapies to treat sepsis and septic shock. Crit Care Med 1997; 25:1095-1100
-
(1997)
Crit Care Med
, vol.25
, pp. 1095-1100
-
-
Zeni, F.1
Freeman, B.2
Natanson, C.3
|